Research
Open Access
Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study
Zaeema Naveed, Julia Li, Michelle Spencer, James Wilton, Monika Naus, Héctor Alexander Velásquez García, Michael Otterstatter and Naveed Zafar Janjua
CMAJ November 21, 2022 194 (45) E1529-E1536; DOI: https://doi.org/10.1503/cmaj.220676
Zaeema Naveed
School of Population and Public Health (Naveed), University of British Columbia; British Columbia Centre for Disease Control (Li, Spencer, Wilton, Naus, Velásquez García, Otterstatter, Janjua), Vancouver, BC
MBBS PhDJulia Li
School of Population and Public Health (Naveed), University of British Columbia; British Columbia Centre for Disease Control (Li, Spencer, Wilton, Naus, Velásquez García, Otterstatter, Janjua), Vancouver, BC
MScMichelle Spencer
School of Population and Public Health (Naveed), University of British Columbia; British Columbia Centre for Disease Control (Li, Spencer, Wilton, Naus, Velásquez García, Otterstatter, Janjua), Vancouver, BC
MScJames Wilton
School of Population and Public Health (Naveed), University of British Columbia; British Columbia Centre for Disease Control (Li, Spencer, Wilton, Naus, Velásquez García, Otterstatter, Janjua), Vancouver, BC
MPHMonika Naus
School of Population and Public Health (Naveed), University of British Columbia; British Columbia Centre for Disease Control (Li, Spencer, Wilton, Naus, Velásquez García, Otterstatter, Janjua), Vancouver, BC
MDHéctor Alexander Velásquez García
School of Population and Public Health (Naveed), University of British Columbia; British Columbia Centre for Disease Control (Li, Spencer, Wilton, Naus, Velásquez García, Otterstatter, Janjua), Vancouver, BC
MD PhDMichael Otterstatter
School of Population and Public Health (Naveed), University of British Columbia; British Columbia Centre for Disease Control (Li, Spencer, Wilton, Naus, Velásquez García, Otterstatter, Janjua), Vancouver, BC
PhD MScNaveed Zafar Janjua
School of Population and Public Health (Naveed), University of British Columbia; British Columbia Centre for Disease Control (Li, Spencer, Wilton, Naus, Velásquez García, Otterstatter, Janjua), Vancouver, BC
MBBS DrPH![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study
Zaeema Naveed, Julia Li, Michelle Spencer, James Wilton, Monika Naus, Héctor Alexander Velásquez García, Michael Otterstatter, Naveed Zafar Janjua
CMAJ Nov 2022, 194 (45) E1529-E1536; DOI: 10.1503/cmaj.220676
Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study
Zaeema Naveed, Julia Li, Michelle Spencer, James Wilton, Monika Naus, Héctor Alexander Velásquez García, Michael Otterstatter, Naveed Zafar Janjua
CMAJ Nov 2022, 194 (45) E1529-E1536; DOI: 10.1503/cmaj.220676
Jump to section
Related Articles
Cited By...
- Covid-19 vaccination decisions and impacts of vaccine mandates: A cross sectional survey of healthcare workers in Ontario, Canada
- Safety and Healthcare Use Following COVID-19 Vaccination Among Adults With Rheumatoid Arthritis: A Population-Based Self-Controlled Case Series Analysis
- Myopericardite persistante apres une vaccination heterologue a ARNm anti-SRAS-CoV-2
- Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis
- Persistent myopericarditis after heterologous SARS-CoV-2 mRNA vaccination
- Booster Vaccination with SARS-CoV-2 mRNA Vaccines and Myocarditis Risk in Adolescents and Young Adults: A Nordic Cohort Study of 8.9 Million Residents